Kahn SE - Search Results

1

Diabetes Care: "Taking It to the Limit One More Time".

Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Kahn SE, Weinger K, Blonde L, de Groot M, Rich S, D'Alessio D, Reynolds L, Riddle MC. Cefalu WT, et al. Among authors: kahn se. Diabetes Care. 2017 Jan;40(1):3-6. doi: 10.2337/dc16-2326. Diabetes Care. 2017. PMID: 27999000 Free PMC article. No abstract available.

2

Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell.

Kahn SE, Fujimoto WY, D'Alessio DA, Ensinck JW, Porte D Jr. Kahn SE, et al. Horm Metab Res. 1991 Dec;23(12):577-80. doi: 10.1055/s-2007-1003759. Horm Metab Res. 1991. PMID: 1723393

3

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr. Kahn SE, et al. Diabetes. 1990 May;39(5):634-8. doi: 10.2337/diab.39.5.634. Diabetes. 1990. PMID: 2185112

4

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW. D'Alessio DA, et al. Among authors: kahn se. Diabetes. 1994 Dec;43(12):1457-61. doi: 10.2337/diab.43.12.1457. Diabetes. 1994. PMID: 7958499

5

Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro.

Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE. Verchere CB, et al. Among authors: kahn se. Diabetologia. 1994 Jul;37(7):725-8. doi: 10.1007/BF00417699. Diabetologia. 1994. PMID: 7958546

6

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW. D'Alessio DA, et al. Among authors: kahn se. J Clin Invest. 1994 May;93(5):2263-6. doi: 10.1172/JCI117225. J Clin Invest. 1994. PMID: 8182159 Free PMC article.

7

Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway.

Kahn SE, Verchere CB, D'Alessio DA, Cook DL, Fujimoto WY. Kahn SE, et al. Diabetologia. 1993 Jun;36(6):570-3. doi: 10.1007/BF02743276. Diabetologia. 1993. PMID: 8335181

8

Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.

Verchere CB, D'Alessio DA, Wang S, Andrikopoulos S, Kahn SE. Verchere CB, et al. Among authors: kahn se. Horm Metab Res. 1997 Jun;29(6):311-6. doi: 10.1055/s-2007-979042. Horm Metab Res. 1997. PMID: 9230354 Review.

9

The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.

Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE. Verchere CB, et al. Among authors: kahn se. Diabetes. 2000 Sep;49(9):1477-84. doi: 10.2337/diabetes.49.9.1477. Diabetes. 2000. PMID: 10969831

10

Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.

Knowles NG, Landchild MA, Fujimoto WY, Kahn SE. Knowles NG, et al. Among authors: kahn se. Diabetes Care. 2002 Feb;25(2):292-7. doi: 10.2337/diacare.25.2.292. Diabetes Care. 2002. PMID: 11815498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page